Equillium

Forecast & Rating9 analysts currently cover Equillium, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $8.56, about 511.1% upside from the current price of $1.40. Price targets range from $4.00 to $20.00 — a wide spread, showing clear disagreement over just how much Equillium can rise. Historically, about 4.6% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Equillium closely still see room for the stock to rise. Data as of Oct 26, 2026; for reference only and not investment advice.